Leucocytoclastic vasculitis in severe ulcerative colitis

Military Medicine

Volumn 176, Issue 5, 2011, Pages 581-583

  Martin, Donald ^a   Handler, Tristan ^a   Mcdermott, Maj Joseph ^a  

^a Department of Internal Medicine ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DERMATOLOGICAL AGENT; INFLIXIMAB; MESALAZINE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CASE REPORT; COLON RESECTION; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; MALE; SOLDIER; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; COLECTOMY; COLITIS, ULCERATIVE; DERMATOLOGIC AGENTS; HUMANS; MALE; MESALAMINE; MILITARY PERSONNEL; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 79960951896     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-10-00409     Document Type: Article

References (18)

1. Timani S, Mutasim DF: Skin manifestations of infl ammatory bowel disease. Clin Dermatol 2008; 26 (3): 265-273.
2. Koutkia P, Mylonakis E, Rounds S, Erickson A: Leucocytoclastic vasculitis: an update for the clinician. Scand J Rheumatol 2001; 30: 315-322.
3. Jessop SJ: Cutaneous leucycytoclastic vasculitis: a clinical and aetiological study. Br J Rheumatol 1995; 34: 942-945.
4. Claudy A: Pathogenesis of leukocytoclastic vasculitis. Eur J Dermatol 1998; 8: 75-9.
5. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al: Cutaneous vasculitis in children and adults: associated diseases and etiological factors in 303 patients. Medicine (Baltimore) 1998; 77: 403-418.
6. Cutri FT, Salerno R, Schiavo AL, Gravina AG, Morano M, Ruocco E: Ulcerative colitis associated with leukocytoclastic vasculitis of the skin. Dig Liver Dis 2009; 41 (7): e42-e44.
7. Iannone F, Scioscia C, Musio A, Poscitelli D, Lapadula G: Leucocytoclastic vasculitis as onset symptom of ulcerative colitis. Ann Rheum Dis 2003; 62: 785-786.
8. Akbulut S, Ozaslan E, Topal F, Albayrak L, Kayhan B, Efe C: Ulcerative colitis presenting as leukocytoclastic vasculitis of skin. World J Gastroenterol 2008; 14: 2448-2450.
9. Newton JA, McGibbon DH, Marsden RA: Leucocytoclastic vasculitis and angio-oedema associated with infl ammatory bowel disease. Clin Exp Dermatol 1984; 9: 618-623.
10. Abraham C, Cho JH: Mechanism of disease: infl amm atory bowel disease. N Engl J Med 2009; 361: 2066-78.
11. Hatoum OA, Heidemann J, Binion DG: The intestinal microvasculature as a therapeutic target in infl ammatory bowel disease. Ann N Y Acad Sci 2006; 1072: 78-97.
12. Mora JR, von Andrian UH: T-cell homing specifi city and plasticity: new concepts and future challenges. Trends Immunol 2006; 27: 235-243.
13. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE: Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 2005; 202: 1703-1713.
14. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP: Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 2008; 134: 145-155.
15. Mora JR, Bono MR, Manjunath N, et al: Selective imprinting of guthoming T cells by Peyer's patch dendritic cells. Nature 2003; 424: 88-93.
16. Jaensson E, Uronen-Hansson H, Pabst O, et al: Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008; 205: 2139-249.
17. Liu Z, Yang L, Cui Y, et al: Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in infl amatory bowel disease. Infl amm Bowel Dis 2009; 15 (8): 1133-1144.
18. Miossec P, Korn T, Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.